Margaret G McGlynn
CIK 1215126 · President, MV & ID · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VRTX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ONE MERCK DRIVE PO BOX 100
WHITEHOUSE STATION, NJ 08889-0100
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVAX | Director | 44,468 | $10.89 | $484.3K | $0 | 10 | 2026-06-23 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 0 | $14.49 | $0 | -$970.5K | 26 | 2026-04-27 |
| VRTX | Director | 178 | $550.87 | $98.1K | -$20.89M | 27 | 2023-05-03 |
| APD | Director | — | $311.08 | — | $0 | 70 | 2020-10-01 |
| MRK | President, MV & ID | 57,471 | $148.76 | $8.55M | $0 | 11 | 2009-04-27 |
Recent Filings · Page 3 of 15
146 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-12 | VRTX | Mixed | — | -$763.4K | EDGAR |
| 2022-04-04 | VRTX | Mixed | — | -$673.6K | EDGAR |
| 2022-02-01 | VRTX | Mixed | — | -$571.3K | EDGAR |
| 2021-06-22 | NVAX | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +10,115 | $0 | EDGAR |
| 2021-06-03 | VRTX | Mixed | −699 | $0 | EDGAR |
| 2021-05-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | — | -$27.6K | EDGAR |
| 2021-05-04 | VRTX | Grant (A) | +921 | $0 | EDGAR |
| 2020-12-09 | NVAX | Grant (A) | — | $0 | EDGAR |
| 2020-10-01 | APD | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.